Bio-Techne (TECH) earnings

Earnings (net income) · fiscal 2026
$181.86M

Bio-Techne (TECH) reported net income of $181.86M in fiscal 2026 (the year ended June 30, 2026). That is 147.8% higher than the $73.40M of fiscal 2025. Figures as of 18 Nov 2026, 01:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2026
$181.86M
Change on fiscal 2025
+147.8%
Growth, 5 years
+5.3% a year
Growth, 10 years
+5.7% a year
Highest on record
$285.26Mfiscal 2023
Lowest on record
$73.40Mfiscal 2025
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bio-Techne earnings, in more detail

Over the five fiscal years to 2026 net income grew at a compound 5.3% a year; over ten years the rate was 5.7% a year. Across the 18 fiscal years on record (2009–2026), the highest was $285.26M in fiscal 2023 and the lowest $73.40M in fiscal 2025.

History · 18 fiscal years

Earnings (net income) by fiscal year

Bio-Techne earnings, year by year

Bio-Techne (TECH) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2026$181.86M 147.8% up
2025$73.40M 56.3% down
2024$168.11M 41.1% down
2023$285.26M 4.9% up
2022$272.05M 93.8% up
2021$140.41M 38.8% down
2020$229.30M 138.7% up
2019$96.07M 23.8% down
2018$126.15M 65.8% up
2017$76.09M 27.2% down
2016$104.48M 3.0% down
2015$107.74M 2.9% down
2014$110.95M 1.4% down
2013$112.56M 0.2% up
2012$112.33M 0.0% up
2011$112.30M 2.3% up
2010$109.78M 4.3% up
2009$105.24M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Bio-Techne and comparable companies
CompanyEarnings (net income)Fiscal year
DaVita DVA$746.80M2025
Halozyme Therapeutics HALO$316.89M2025
Universal Health Services UHS$1.49B2025
Repligen RGEN$48.89M2025
Bio-Techne TECH$181.86M2026
BioMarin Pharmaceutical BMRN$348.90M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TECH

Bio-Techne, figure by figure

Bio-Techne (TECH) overview: price, valuation and scorecardAll health care companies by market value

Bio-Techne earnings: questions and answers

What is Bio-Techne's net income?

Bio-Techne (TECH) reported net income of $181.86M in fiscal 2026 (the year ended June 30, 2026). That is 147.8% higher than the $73.40M of fiscal 2025.

What is the growth rate of Bio-Techne's net income?

Over the five fiscal years to 2026 net income grew at a compound 5.3% a year; over ten years the rate was 5.7% a year.

What are the highest and lowest net income figures on record for Bio-Techne?

Across the 18 fiscal years on record (2009–2026), the highest was $285.26M in fiscal 2023 and the lowest $73.40M in fiscal 2025.

How is Bio-Techne's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bio-Techne (TECH) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/TECH/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.